Workers' Compensation Board Regulation

B.C. Reg. 203/2023: Amendments to the Occupational Health and Safety Regulation

Made under the Workers Compensation Act

How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →

Get alerted when the next rule lands

New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

The rule, in full

2,877 words as published, August 29, 2023. View the original →

B.C. Reg. 203/2023, deposited August 28, 2023, under the WORKERS COMPENSATION ACT [sections 110, 111 and 117]. Resolution of the Workers’ Compensation Board, dated August 23, 2023. The Workers’ Compensation Board orders that, effective December 1, 2023, the Occupational Health and Safety Regulation, B.C. Reg. 296/97, is amended as set out in the attached Appendix. — B. DHILLON, Chair, Board of Directors.

Appendix

1 The heading before section 6.42 of the Occupational Health and Safety Regulation, B.C. Reg. 296/97, is repealed and the following substituted: Hazardous Drugs . 2 Sections 6.42 to 6.58 are repealed and the following substituted:

Definitions

6.42 In this section and sections 6.43 to 6.58: "decontamination" means the removal, inactivation or destruction of a hazardous drug that is or may be on a surface, material or thing; "emergency decontamination" means decontamination in response to a spill or an emergency that involves, or may involve, a hazardous drug, but does not include routine decontamination performed as part of housekeeping; "exposure control plan" means an exposure control plan under section 6.46; "hazardous drug" means a drug that (a) has one or more of the following characteristics: (i) carcinogenicity; (ii) teratogenicity; (iii) genotoxicity; (iv) reproductive toxicity; (v) organ toxicity at low doses, (b) is a new drug that mimics, in structure or toxicity, an existing drug known to be a hazardous drug according to the characteristics listed in paragraph (a), or (c) is identified in the NIOSH list as a hazardous drug; "housekeeping" includes the following: (a) routine cleaning; (b) routine decontamination; (c) changing, handling, laundering or other cleaning and disposal of things contaminated with the excreta, vomit or bodily fluids of patients; "NIOSH list" means the NIOSH List of Hazardous Drugs in Healthcare Settings, prepared by the United States National Institute for Occupational Safety and Health, as amended from time to time; "precautionary period" means the period of time during which the excreta, vomit or bodily fluids of a patient treated with a hazardous drug are contaminated by the hazardous drug or a hazardous metabolite of the hazardous drug, determined in accordance with any of the following information: (a) information provided by the manufacturer or a supplier of the hazardous drug; (b) information provided by a pharmacist or physician; (c) information in a scientific publication; "risk assessment" means a risk assessment under section 6.45; "work procedures" means work procedures under section 6.46.1.

Application

6.43 Sections 6.44 to 6.58 apply in relation to a workplace at which a worker is or may be exposed to a hazardous drug.

Identifying hazardous drugs

6.44 An employer must do all of the following: (a) develop a written list of every hazardous drug that a worker is or may be exposed to at a workplace; (b) review the list at least annually and, if necessary, update the list; (c) ensure the list is made readily available for reference by workers at each of the workplaces to which the list applies.

Risk assessment

6.45 (1) An employer must ensure that a qualified person prepares a written risk assessment for the hazardous drugs identified in the list developed under section 6.44. (2) A risk assessment must consider at least the following: (a) information about the hazardous properties of the hazardous drug, including any information provided by manufacturers, suppliers or pharmacists, or in scientific publications, with respect to (i) the active ingredients of the hazardous drug and the concentration of those ingredients, (ii) the potential harmful health effects of exposure to the hazardous drug, including both acute and chronic effects and reproductive effects, (iii) whether exposure to multiple hazardous drugs may increase the risk of harmful health effects, and (iv) any special precautions a worker is advised to take; (b) the scope, circumstances and nature of the work activities related to a hazardous drug, including (i) the classification, formulation and quantity of the hazardous drug, (ii) the frequency and duration of exposure to the hazardous drug, (iii) whether the potential for exposure may increase if the form of the hazardous drug is altered during a work activity by crushing, dissolving, piercing or mixing that hazardous drug or by opening a container or package that holds that hazardous drug, and (iv) whether another worker in the same work area may be at risk of exposure to the hazardous drug; (c) the effectiveness of existing and planned control measures to eliminate or minimize exposure to the hazardous drug, taking into account, if applicable, (i) information respecting a spill, uncontrolled release or accidental exposure, and (ii) environmental monitoring or exposure monitoring data; (d) any additional information relevant to the risk from the hazardous drug. (3) The employer must ensure that the risk assessment is reviewed and, if necessary, updated by a qualified person if any of the following occur: (a) a new hazardous drug is introduced into a workplace to which the risk assessment applies; (b) drug handling practices, or other work activities that may cause a worker to be at risk of exposure to a hazardous drug, are changed; (c) available information indicates that controls implemented under the exposure control plan are not effective. (4) A risk assessment must be prepared in consultation with a joint committee or worker health and safety representative, as applicable, for a workplace to which the risk assessment applies.

Exposure control plan

6.46 (1) An employer must (a) ensure that a qualified person develops an exposure control plan that (i) meets the requirements of section 5.54 (2), and (ii) addresses the hazards identified in the risk assessment, and (b) implement the exposure control plan developed and updated under this section. (2) The employer must (a) review an exposure control plan at least annually, and, if necessary, update the exposure control plan, and (b) if necessary, update an exposure control plan to address any changes to a risk assessment for the workplace. (3) An exposure control plan must be developed, reviewed and updated in consultation with a joint committee or worker health and safety representative, as applicable, for a workplace to which the exposure control plan applies.

Work procedures

6.46.1 (1) For the purposes of complying with section 5.54 (2) (d), an employer must ensure that written work procedures required to be incorporated into an exposure control plan are prepared by a qualified person. (2) Work procedures must address the following, as applicable: (a) a work activity relating to (i) the manufacture, receipt, preparation, administration, storage and disposal of a hazardous drug, (ii) housekeeping, and (iii) emergency decontamination; (b) any other work activity in which a worker is or may be exposed to a hazardous drug; (c) the containment or enclosure, as a control measure, of a work activity or a work process; (d) the provision of, and the correct selection, use, care, maintenance and disposal of, any required personal protective equipment and clothing; (e) prohibitions on eating, drinking, storing food and applying personal care products in an area in which a hazardous drug is present; (f) handwashing and related protocols; (g) reporting and response procedures for incidents that involve (i) accidental exposure to a hazardous drug, or (ii) a spill or uncontrolled release of a hazardous drug; (h) the identification, removal, cleanup and disposal of waste related to a hazardous drug, which waste may include (i) anything contaminated by the hazardous drug, and (ii) anything contaminated during the precautionary period applicable to the hazardous drug by excreta, vomit or bodily fluids from a patient treated with the hazardous drug. (3) The employer must ensure that work procedures are made readily available for reference by workers at each of the workplaces to which the work procedures apply.

Reproductive toxins

6.47 If a worker is or may be exposed to a hazardous drug that is a reproductive toxin, an employer must develop (a) a written policy about the availability of protective reassignment, and (b) a procedure for determining if protective reassignment is appropriate for workers who advise the employer of a pregnancy or an intent to conceive a child.

Eliminating or controlling exposure

6.48 (1) An employer must, if practicable, eliminate the risk of worker exposure to a hazardous drug. (2) If elimination under subsection (1) is not practicable, the employer must control the risk of worker exposure to a hazardous drug using substitution. (3) In selecting a suitable substitute, the employer must ensure that the hazards of the substitute are known and that the risk to workers is reduced by its use. (4) If substitution under subsection (2) is not practicable, the employer must control the risk of worker exposure to a hazardous drug, keeping the risk as low as reasonably achievable, by doing the following: (a) applying engineering controls and administrative controls that are appropriate in relation to the work activity and consistent with the risk assessment for the workplace; (b) ensuring that a worker who is or may be exposed to a hazardous drug (i) is provided with personal protective equipment appropriate to the work activity as identified in the applicable work procedures, and (ii) uses the personal protective equipment in accordance with the instruction and training provided under section 6.51.

Contaminated personal protective equipment

6.49 (1) An employer must ensure that contaminated or potentially contaminated personal protective equipment, including gowns and gloves, is not worn outside an area in which a hazardous drug is manufactured, prepared, administered or stored or in which waste contaminated by a hazardous drug is handled. (2) An employer must ensure that non-disposable personal protective equipment is cleaned and decontaminated after use in accordance with the work procedures applicable to the workplace.

Preparation and administration of certain hazardous drugs

6.50 (1) In this section, "IARC Monographs" means the IARC Monographs on the Identification of Carcinogenic Hazards to Humans published by the International Agency for Research on Cancer, as amended from time to time. (2) This section applies to the following hazardous drugs: (a) a hazardous drug that is identified in the NIOSH list as being antineoplastic; (b) a hazardous drug for which the manufacturer recommends ventilated engineering controls; (c) a hazardous drug that is classified by the IARC Monographs as a Group 1 or Group 2A carcinogen. (3) An employer must ensure that all of the following work activities are performed in a ventilated enclosure that meets the requirements set out in subsection (4): (a) mixing a hazardous drug to which this section applies; (b) preparing a hazardous drug to which this section applies; (c) priming an intravenous administration set with a solution containing a hazardous drug to which this section applies. (4) For the purposes of subsection (3), a ventilated enclosure must (a) meet or exceed the requirements for a Class II Type B2 biological safety cabinet that conforms to NSF/ANSI Standard 49-2018 Biosafety Cabinetry: Design, Construction, Performance, and Field Certification, (b) have exhaust and ventilation systems that remain in operation for a period of time sufficient to ensure that no contaminants escape into the workplace, (c) be connected to the exhaust ventilation system, which system must discharge to the outdoors in a manner that prevents contaminants from being recirculated in the workplace or an adjacent workplace, and (d) be equipped with a continuous monitoring device to permit confirmation of adequate airflow and cabinet performance. (5) An employer must ensure that hazardous drugs to which this section applies are administered in accordance with the applicable work procedures.

Instruction and training

6.51 (1) An employer must ensure that a worker who is or may be exposed to a hazardous drug is provided with instruction and training on the safe handling of the hazardous drug. (2) The instruction and training under subsection (1) must address all of the following: (a) known health effects, including reproductive health effects, caused by exposure to the hazardous drug; (b) the applicable work procedures, including the procedures to be followed in the event of a spill, uncontrolled release or accidental exposure to the hazardous drug; (c) the correct selection, use, care, maintenance and disposal of personal protective equipment and clothing. (3) The employer must (a) review the adequacy of the instruction and training provided under this section if there is a change to (i) the hazardous drug, or (ii) handling practices, work activities or the information available respecting the hazardous drug, and (b) if necessary, ensure that further instruction or training is provided. (4) Instruction and training under subsection (1) must be provided in consultation with a joint committee or worker health and safety representative, as applicable, for a workplace in relation to which the instruction and training are provided.

Supervision

6.52 An employer must ensure that a worker who is or may be exposed to a hazardous drug at a workplace is (a) effectively supervised, and (b) required to follow all work procedures applicable to the workplace.

Spill kits

6.53 An employer must ensure that clearly labelled spill kits (a) are kept in or near any area in which a hazardous drug is manufactured, received, prepared, administered, stored or transported, and (b) are readily available to workers.

Storing and labelling hazardous drugs

6.54 (1) An employer must ensure that a hazardous drug is stored as follows: (a) if practicable, in a designated area that meets the requirements set out in subsection (2); (b) in accordance with the exposure control plan and the manufacturer’s instructions, if any. (2) For the purposes of subsection (1) (a), the requirements for the designated area are as follows: (a) the area must be designed and constructed to provide for the safe containment of hazardous drugs; (b) clearly visible signs warning that hazardous drugs are stored in the area must be prominently posted; (c) the area must not be located within any other area designated or regularly used for eating, changing clothes or storing personal items; (d) access to the area must be restricted to authorized workers. (3) An employer must ensure that any container, bin or shelf, in or on which a hazardous drug is stored, is correctly and clearly labelled.

Transporting hazardous drugs

6.55 (1) In this section, "transport" includes transport within a workplace. (2) An employer must ensure that, during transport, a hazardous drug is (a) in a sealed container, labelled with a unique and recognizable identifier to distinguish the hazardous drug from other drugs, and (b) packaged in a manner that minimizes the risk of environmental contamination if there is a spill, leak or uncontrolled release of the hazardous drug.

Handling and disposing of waste

6.56 (1) For the purposes of this section, the following things are considered to be waste related to a hazardous drug: (a) during the precautionary period applicable to the hazardous drug, excreta, vomit or bodily fluids from a patient treated with the hazardous drug; (b) anything disposable that is contaminated by the hazardous drug or by waste referred to in paragraph (a). (2) Subject to subsection (3), an employer must ensure that all waste related to a hazardous drug is handled and disposed of in accordance with the manufacturer’s instructions, if any. (3) An employer must ensure that all waste that is related to a hazardous drug and handled by a worker is disposed of by placing the waste in a container or bag referred to in subsection (4). (4) An employer must ensure that every area in which a hazardous drug is manufactured, prepared, administered or stored is supplied with (a) clearly labelled, leak-proof and sealable waste disposal containers, including puncture- and fluid-resistant sharps containers and solids containers, and (b) if appropriate, distinctive sealable plastic waste bags.

Controlling cross-contamination

6.57 An employer must ensure that equipment and products used for housekeeping and emergency decontamination are (a) designated for use only in relation to hazardous drugs, and (b) readily available for use.

Records

6.58 (1) An employer must keep a record of all instruction and training provided under section 6.51 for a period of 3 years after the date the instruction or training is provided. (2) An employer must, for each worker who prepares a hazardous drug, keep a record that includes the following: (a) the name of each hazardous drug prepared by the worker; (b) if practicable, the number of preparations per week; (c) each risk assessment prepared, and each exposure control plan developed, including any updates, that (i) is relevant to the worker’s employment, and (ii) applied to the worker at any time during the period of the worker’s employment. (3) An employer must, for each worker who administers a hazardous drug, keep a record that includes the following: (a) the name of each hazardous drug administered by the worker (i) parenterally, (ii) orally, in the case of a hazardous drug in powder or liquid form or contained in a capsule that was opened, or (iii) by topical application; (b) if practicable, the number of administrations per week; (c) each risk assessment prepared, and each exposure control plan developed, including any updates, that (i) is relevant to the worker’s employment, and (ii) applied to the worker at any time during the period of the worker’s employment. (4) An employer must keep a record referred to in subsection (2) or (3) for the period of employment of the worker to whom the record relates and for the 10-year period after the end of that worker’s employment.